title: Dapagliflozin, an SGLT2 inhibitor, for diabetes.
authors.affiliation: Centre for Clinical Studies, Gesellschaft für Wissens-und Technologietransfer, Technical University Dresden, 01307 Dresden, Germany. hanefeld@gwtonline-zks.de
authors.forename: Markolf
authors.initials: M
authors.lastname: Hanefeld
authors.forename: Thomas
authors.initials: T
authors.lastname: Forst
mesh_terms: D001559:Benzhydryl Compounds; D001786:Blood Glucose / Q000032:analysis; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D005960:Glucosides / Q000627:therapeutic use*; D006029:Glycosuria; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D000077203:Sodium-Glucose Transporter 2 Inhibitors
chemical_list: D001559:Benzhydryl Compounds; D001786:Blood Glucose; D005960:Glucosides; D007004:Hypoglycemic Agents; D000077203:Sodium-Glucose Transporter 2 Inhibitors; C529054:dapagliflozin